Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesEvaluating the Incremental Benefits of Raising High-Density Lipoprotein Cholesterol Levels During Lipid Therapy After Adjustment for the Reductions in Other Blood Lipid Levels
Archives of Internal Medicine, 10/30/09
Grover SA et al. – Raising HDL–C levels with commonly used lipid medications appears to be an important determinant of the benefits associated with lipid therapy. These results support the further evaluation of therapies to raise HDL–C levels to prevent CV events.
Related Articles
Management of Hypercholesterolemia
Geriatrics & Aging, 11/12/09
Relevance Score: 94%
Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort
Cancer Causes and Control, 10/13/09
Relevance Score: 92%
Low cholesterol may prevent some prostate cancers
USA Today, 11/05/09
Relevance Score: 91%
Statins Creating a Social Gap in Cholesterol Levels
Internet Source, 10/16/09
Relevance Score: 91%
Study Demonstrates LIVALO Is an Efficacious Treatment for Achieving Lipid Goals
Internet Source, 10/23/09
Relevance Score: 90%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Relation Among Lipoprotein Subfractions and Carotid Atherosclerosis in Alaskan Eskimos (from the GOCADAN Study)
The American Journal of Cardiology, 12/02/09
Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review
American Journal of Clinical Nutrition, 12/02/09
Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)
The American Journal of Cardiology, 12/02/09
Sponsor
Article Search
Sponsor
Sponsor